TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Laerdal Medical AS
Closing information (x1000 NOK)
| Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Turnover |
5,276,133
|
4,443,675
|
4,034,274 |
| Financial expenses |
3,677
|
-950
|
8,269 |
| Earnings before taxes |
856,639
|
831,804
|
607,223 |
| Total assets |
5,223,148
|
4,546,687
|
3,868,976 |
| Current assets |
4,057,083
|
3,601,721
|
2,970,106 |
| Current liabilities |
1,884,856
|
1,762,404
|
1,335,718 |
| Equity capital |
2,916,236
|
2,428,842
|
2,275,909 |
| - share capital |
16,188
|
16,188
|
16,188 |
Financial ratios
| Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Solvency |
55.8%
|
53.4%
|
58.8% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
16.2%
|
18.7%
|
15.1% |
| Return on assets (ROA) |
16.5%
|
18.3%
|
15.9% |
| Current ratio |
215.2%
|
204.4%
|
222.4% |
| Return on equity (ROE) |
29.4%
|
34.2%
|
26.7% |
| Change turnover |
832,458
|
409,401
|
172,791 |
| Change turnover % |
19%
|
10%
|
4% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.